Long-COVID is rapidly becoming one of the most common chronic diseases worldwide. However, the pathogenic mechanisms underlying the development of this new disease are still largely poorly understood. Recent evidence suggests that pre-existing inflammatory lung diseases may increase the risk of developing long-COVID, including chronic fatigue.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Findings from research on the generalization of exposure therapy
Treatment of comorbid anxiety
- Symptom-free despite asthma?
Asthma treatment requirements have increased
- Phytotherapy for rhinosinusitis
Evidence, active substances and clinical classification for medical practice
- Pulmonary hypertension
PH and lung diseases
- Contact eczema
Causes and prevention at work
- Respiratory infections: viral bronchitis or bacterial pneumonia?
Old crucial question in the light of current findings
- What biomarkers reveal about "biological youth" - and what not (yet)
Epigenetic ageing
- Amyotrophic lateral sclerosis and nutrition